The European Medicines Agency review of ipilimumab (Yervoy) for the treatment of advanced (unresectable or metastatic) melanoma in adults who have received prior therapy: Summary of the scientific assessment of the Committee for Medicinal Products for Human Use
2012 ◽
Vol 48
(2)
◽
pp. 237-242
◽
Keyword(s):
2013 ◽
Vol 49
(7)
◽
pp. 1654-1661
◽
2011 ◽
Vol 17
(21)
◽
pp. 6608-6614
◽
2013 ◽
Vol 25
(5)
◽
pp. 371-374
◽
2012 ◽
Vol 18
(17)
◽
pp. 4491-4497
◽
2014 ◽
Vol 24
(4)
◽
pp. 457-463
◽
Keyword(s):
2011 ◽
Vol 16
(10)
◽
pp. 1451-1457
◽